SCHEMBL4098500

SCHEMBL4098500

Cc1ccc(Sc2ccc(N)cc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.74
CYP3A4 P08684 1/20 0.74
TSHR P16473 1/20 0.74
ACHE P22303 2/20 0.68
TEAD4 Q15561 1/20 0.52
MAPT P10636 7/20 0.50
TDP1 Q9NUW8 6/20 0.50
ALDH1A1 P00352 4/20 0.50
POLB P06746 1/20 0.50
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
MLYCD O95822 1/20 0.45
PDE7A Q13946 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ANXA2 P07355 1/20 0.42
S100A10 P60903 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1098379 0.86 CYP3A4 (1.00) MAPK1CYP3A4TSHRACHEMAPT
SCHEMBL9647870 0.86 CYP3A4 (1.00) MAPK1CYP3A4TSHRACHEMAPT
SCHEMBL9485438 0.86 CYP3A4 (1.00) MAPK1CYP3A4TSHRACHEMAPT
SCHEMBL83853 0.86 ACHE (0.57) MAPK1CYP3A4TSHRACHEMAPT
SCHEMBL9649030 0.86 CYP3A4 (1.00) MAPK1CYP3A4TSHRACHEMAPT
SCHEMBL9485453 0.86 CYP3A4 (1.00) MAPK1CYP3A4TSHRACHEMAPT
4,4'-Thiodianiline SCHEMBL49068 0.86 CYP3A4 (1.00) MAPK1CYP3A4TSHRACHEMAPT
SCHEMBL12245875 0.86 ACHE (0.57) MAPK1CYP3A4TSHRACHEMAPT
SCHEMBL10813732 0.86 CYP3A4 (1.00) MAPK1CYP3A4TSHRACHEMAPT
SCHEMBL9647766 0.86 CYP3A4 (1.00) MAPK1CYP3A4TSHRACHEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12024596-B2 Anti-solvent technique for recovering an organic solvent from a polyarylene sulfide waste sludge TICONA LLC (US) 2024-07-02 US disclosed
WO-2023226264-A1 HYPERBRANCHED POLYPHENYL AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 苏州大学 2023-11-30 WO disclosed
EP-4039782-B1 POLYMERS AND LUBRICATING COMPOSITIONS CONTAINING POLYMERS INFINEUM INT LTD (GB) 2023-10-18 EP disclosed
EP-3901162-A1 GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF AbbVie Inc. (US) 2021-10-27 EP disclosed
WO-2021200276-A1 CURABLE RESIN COMPOSITION AND DISPLAY DEVICE 住友化学株式会社 2021-10-07 WO disclosed
WO-2021200277-A1 CURABLE RESIN COMPOSITION AND DISPLAY DEVICE 住友化学株式会社 2021-10-07 WO disclosed
EP-3770235-A1 POLYMERS AND LUBRICATING COMPOSITIONS CONTAINING POLYMERS Infineum International Limited (GB) 2021-01-27 EP disclosed
US-20200338208-A1 GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF ABBVIE INC. (US) 2020-10-29 US disclosed
WO-2019070727-A2 NONVIRAL GENE TRANSFER TO THE SUPRACHOROIDAL SPACE THE JOHNS HOPKINS UNIVERSITY (US) 2019-04-11 WO disclosed
US-9999905-B2 Polymeric coatings and coating method INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2018-06-19 US disclosed
EP-0103541-B1 ANTHRAQUINONE DYES, THEIR PREPARATION AND USE CIBA-GEIGY AG (CH) 1989-07-19 EP disclosed
US-4771062-A ENZYME INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 1988-09-13 US disclosed
EP-0240680-A1 Diaryl sulfide derivatives BAYER AG (DE) 1987-10-14 EP disclosed
EP-0231888-A2 Substituted 2,4-diamino-5-benzyl pyrimidines, their preparation and their use as medicines having an antimicrobian activity Fatol Arzneimittel GmbH (DE) 1987-08-12 EP disclosed
US-4501592-A Anthraquinone dyes, process for their preparation, and use thereof CIBA-GEIGY CORPORATION (US) 1985-02-26 US disclosed
EP-0103541-A2 Anthraquinone dyes, their preparation and use CIBA-GEIGY AG (CH) 1984-03-21 EP disclosed
US-4332884-A USING A DIOXIME CHELATING AGENT RICOH CO., LTD. (JP) 1982-06-01 US disclosed
US-4306014-A AMMONIA OR AMINES SUPPRESS THE COLOR-FORMING REACTION SYSTEM RICOH CO., LTD. (JP) 1981-12-15 US disclosed
US-4277398-A ORANGE-COLORED, COUNTERACTING UNWANTED ABSORPTION OF MAGENTA DYES IN COLOR PHOTOGRAPHY CIBA-GEIGY AG (CH) 1981-07-07 US disclosed
US-4198407-A Substituted 2-phenyl-1,2,4-triazine-3,5(2H,4H)-diones, and coccidiostatic agents containing same HOECHST AKTIENGESELLSCHAFT (DE) 1980-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200338208-A1 GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF NR3C1, NR3C2, MC2R MAPK1 2345/4885CYP3A4 1655/4885TSHR 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.